Publications

Show Filters

Searches all publications.

Search Term

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-06-25
    E.g., 2018-06-25

Articles

257319 items
12:00 AM, Jun 05, 1995  |  BioCentury | Tools & Techniques

Fat mice tell little

Fat mice tell little Separate reports delving further into two obesity-related gene defects in mice have shed only a little more light on what could cause humans to become overweight. Neither the ob or fat...
12:00 AM, Jun 05, 1995  |  BC Week In Review | Company News  |  Deals

Lidak deal

LDAKA will not proceed with the acquisition of Scherer Healthcare Inc.'s Biofor rational drug design subsidiary for $10 million in LDAKA common stock. LDAKA, which announced the proposed deal in mid-May (see BioCentury May 15),...
12:00 AM, Jun 05, 1995  |  BC Week In Review | Company News  |  Deals

Medco deal

(See Regulatory item below) Medco Research Inc. (MRE)   MRE (Research Triangle Park, N.C.) and Abbott Laboratories terminated their manufacturing and marketing agreements for MRE's Adenoscan. The termination follows the settlement last month of...
12:00 AM, Jun 05, 1995  |  BC Week In Review | Company News  |  Other News

PerSeptive news

PBIO (Framingham, Mass.) reached an agreement in principle to settle for $12 million the class action securities litigation brought against the company last December after PBIO said it would have to restate its prior financial...
12:00 AM, Jun 05, 1995  |  BC Week In Review | Clinical News  |  Clinical Results

TCR peptide data

The Palo Alto company presented results of a physician-sponsored Phase I trial in 11 patients, showing that the TCR peptide engendered enhanced immune responses from regulatory T cells that release cytokines when they encounter abnormal...
12:00 AM, Jun 05, 1995  |  BC Week In Review | Clinical News  |  Regulatory

Quidel regulatory update

Quidel Corp. (QDEL)   QDEL's QuickVue Chlamydia Test received FDA approval. The immunoassay provides results in 12 minutes. Clinical studies of the test showed it had 92 percent sensitivity. The San Diego company's medical and...
12:00 AM, Jun 05, 1995  |  BC Week In Review | Company News  |  Deals

Emisphere deal

Emisphere Technologies Inc. (EMIS)   EMIS (Hawthorne, N.Y.) and Pasteur Merieux will conduct proof of concept studies using EMIS's proteinoid oral drug delivery system (PODDS) with a flu vaccine. EMIS, which will test whether it...
12:00 AM, Jun 05, 1995  |  BC Week In Review | Clinical News  |  Regulatory

Hemagen regulatory update

HMGN received FDA approval to market an Elisa test to detect Chagas disease, an insect-borne parasitic disease that also can be transmitted by blood transfusions. Boehringer Mannheim sells HMGN's Chagas test in South America, while...
12:00 AM, Jun 05, 1995  |  BC Week In Review | Clinical News  |  Regulatory

Celgene regulatory update

Celgene Corp. (CELG)   The FDA granted Orphan Drug designation for Synovir, CELG's thalidomide compound, to treat recurrent aphthous ulcers (canker sores) in immunocompromised patients. Synovir also has Orphan Drug designation to treat clinical manifestations...
12:00 AM, Jun 05, 1995  |  BC Week In Review | Clinical News  |  Regulatory

Lifecore regulatory update

The Chaska, Minn., company received certification of conformance to ISO 9001 Standards and Medical Device Directives as well as the Commission Europeen Mark of Conformity from TUV Product Services of Munich. The designations reflect quality...

Pages